Recruiting Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910 Conditions Adenophorea Infections, Adenoviridae Infections, Adenovirus, +163 more Locations Institut Pasteur du Cambodge — Phnom Penh, Cambodia View Trial Details
Completed Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults NCT05398796 Conditions Henipavirus Infections, Infections, Mononegavirales Infections, +4 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects NCT06221813 Conditions Henipavirus Infections, Infections, Mononegavirales Infections, +4 more Locations Cenexel ACT (Anaheim Clinical Trials) — Anaheim, California, United States Cenexel RCA (Research Centers of America) — Hollywood, Florida, United States Cenexel JBR (JBR Clinical Research) — Salt Lake City, Utah, United States View Trial Details
Completed A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects NCT05178901 Conditions Animal Diseases, Henipavirus Infections, Infections, +6 more Locations Johnson County Clin-Trials(JCCT) — Lenexa, Kansas, United States View Trial Details
Completed Safety and Immunogenicity of a Nipah Virus Vaccine NCT04199169 Conditions Henipavirus Infections, Infections, Mononegavirales Infections, +4 more Locations Cincinnati Children's Hospital Medical Center (CCHMC) — Cincinnati, Ohio, United States View Trial Details
